Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting TRAfs for therapeutic intervention.

Juan M Zapata1, Sophie Lefebvre, John C Reed

  • 1Burnham Institute for Medical Research, La Jolla, California 92037, USA. jzapata@burnham.org

Advances in Experimental Medicine and Biology
|July 18, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peripheral intravenous catheter use in French emergency departments (CathIRU study): a multicentre cross-sectional study of non-indicated insertion rate and practice patterns.

The Lancet regional health. Europe·2026
Same author

Emotional distress of callers requesting emergency medical communication center assistance and patient outcomes: a prospective observational study.

BMC emergency medicine·2025
Same author

Editorial: Community series in mouse models of B cell malignancies, volume II.

Frontiers in immunology·2024
Same author

CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects.

Science advances·2023
Same author

K63 ubiquitination in immune signaling.

Trends in immunology·2022
Same author

Editorial: Mouse Models of B Cell Malignancies.

Frontiers in immunology·2021
Same journal

Peptidomics in the Spotlight: Advanced Sample Treatment Techniques and Analytical Insights.

Advances in experimental medicine and biology·2026
Same journal

Methods for the Investigation of Protein-Ligands Interactions.

Advances in experimental medicine and biology·2026
Same journal

Sample Preparation Strategies for Microbial Cell Surface Proteomics: Integrating Shaving and Shotgun Approaches.

Advances in experimental medicine and biology·2026
Same journal

Proteomic Sample Preparation for the Petroleum Industry: A Biocorrosion Case Study.

Advances in experimental medicine and biology·2026
Same journal

Proteomic and Functional Comparison of Extracellular Vesicles from Wild-Type and Lyn-Deficient Stromal Cells.

Advances in experimental medicine and biology·2026
Same journal

Proteomic Analysis of Histone Sequence Variants and Post-translationally Modified Forms.

Advances in experimental medicine and biology·2026
See all related articles

Tumor necrosis factor receptor-associated factors (TRAFs) are key signaling molecules in cellular responses. This review explores their role in diseases and potential therapeutic strategies targeting TRAFs.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Tumor necrosis factor receptor-associated factors (TRAFs) are crucial signaling adaptors that initiate downstream pathways upon TNF-receptor activation.
  • TRAFs orchestrate receptor-ligand complex dynamics, protein recruitment, and degradation, thereby modulating cellular responses.
  • Dysregulation of TRAF-mediated signaling is implicated in various pathologies.

Purpose of the Study:

  • To review the diverse roles of TRAF family members in disease etiology.
  • To evaluate the therapeutic potential of targeting TRAFs using TNFR-mimic-peptides or small molecule modulators.
  • To discuss the advantages and disadvantages of TRAF-targeted therapeutic strategies.

Main Methods:

  • Literature review of TRAF function in cellular signaling and disease.

Related Experiment Videos

  • Analysis of existing and potential therapeutic interventions targeting TRAF proteins.
  • Discussion of the implications for treating pathologies involving TNF-receptor signaling.

    • Main Results:

    • TRAFs play critical roles in diverse signaling pathways, influencing inflammation, immunity, and cell survival.
    • Evidence suggests that TRAF family members are involved in the pathogenesis of numerous diseases.
    • Both TNFR-mimic-peptides and small molecule TRAF modulators present potential therapeutic avenues.

    Conclusions:

    • TRAFs are central regulators of TNF-receptor signaling with significant implications in disease.
    • Targeting TRAFs offers a promising, albeit complex, therapeutic strategy for various pathologies.
    • Further research is needed to optimize TRAF-targeted therapies and mitigate potential side effects.